a randomized, open-label, prospective, multicenter phase-iii clinical trial of elores in lower respiratory tract and urinary tract infections:一项随机,开放标签,前瞻性,对elores下呼吸道和尿路感染的多中心iii期临床试验.pdfVIP

a randomized, open-label, prospective, multicenter phase-iii clinical trial of elores in lower respiratory tract and urinary tract infections:一项随机,开放标签,前瞻性,对elores下呼吸道和尿路感染的多中心iii期临床试验.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a randomized, open-label, prospective, multicenter phase-iii clinical trial of elores in lower respiratory tract and urinary tract infections:一项随机,开放标签,前瞻性,对elores下呼吸道和尿路感染的多中心iii期临床试验

j o u r n a l o f p h a r m a c y r e s e a r c h 6 ( 2 0 1 3 ) 4 0 9 e4 1 4 Available online at journal homepage: www.el /locate/jopr Original Article A randomized, open-label, prospective, multicenter phase-III clinical trial of Elores in lower respiratory tract and urinary tract infections Manu Chaudhary, Anurag Payasi* Department of Cell Culture and Molecular Biology, Venus Medicine Research Centre, Baddi, Bhatoli Kalan, H.P 173205, India a r t i c l e i n f o a b s t r a c t Article history: Background: Lower respiratory tract infections (LTRIs) and urinary tract infections (UTIs) are Received 20 March 2013 the leading causes of death world-wide. Treatment of these infections require the use of Accepted 10 April 2013 antibiotics with enhanced activity against a broad spectrum of respiratory and urinary Available online 3 May 2013 pathogens. This study was designed to study clinical and bacteriological efficacy as well as tolerability of ceftiaxone þ disodium edtate þ sulbactam (the novel Antibiotic Adjuvant Keywords: Entity; Elores) in adult patients in the treatment of lower respiratory tract infections (LRTIs) Antibiotic adjuvant entity and urinary tract infections (UTIs). Clinical trial Methods: A randomized, open-label, multicenter study was conducted on 297 patients Elores which included 204 in UTIs and 93 in LRTIs. A total of 148 patients were there in Elores Phase-III group with 102 cases of UTIs and 46 LRTIs; 149

您可能关注的文档

文档评论(0)

ajgoaw + 关注
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档